Clinical Trials in Shijiazhuang, China
Locations / Shijiazhuang, China
Delta Trials records 1,383 clinical trials conducted in Shijiazhuang, China, making it a notable site of clinical research activity. These trials across 1,142 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 56 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Shijiazhuang has changed over time.
1383
Total Trials
1142
Conditions
56
Terminated since 2020
Browse by condition (1142 total)
- Breast cancer 37 trialsAll Breast cancer trials
- Non-small cell lung cancer 34 trialsAll Non-small cell lung cancer trials
- Gastric cancer 28 trialsAll Gastric cancer trials
- Diabetes mellitus, type 2 19 trialsAll Diabetes mellitus, type 2 trials
- Type 2 diabetes mellitus 19 trialsAll Type 2 diabetes mellitus trials
- Asthma 18 trialsAll Asthma trials
- Heart failure 16 trialsAll Heart failure trials
- Coronary artery disease 16 trialsAll Coronary artery disease trials
- Atrial fibrillation 15 trialsAll Atrial fibrillation trials
- Stroke 12 trialsAll Stroke trials
- Chronic obstructive pulmonary disease 10 trialsAll Chronic obstructive pulmonary disease trials
- Advanced solid tumor 10 trialsAll Advanced solid tumor trials
- Plaque psoriasis 10 trialsAll Plaque psoriasis trials
- Type 2 diabetes 10 trialsAll Type 2 diabetes trials
- Acute ischemic stroke 10 trialsAll Acute ischemic stroke trials
- Gastroesophageal junction adenocarcinoma 10 trialsAll Gastroesophageal junction adenocarcinoma trials
- Obesity 9 trialsAll Obesity trials
- Atopic dermatitis 9 trialsAll Atopic dermatitis trials
- Migraine 8 trialsAll Migraine trials
- All Chronic obstructive pulmonary disease (COPD) trials